Kitchener · ON, Canada · founded 2012 · https://www.bynorth.com
Diligence memoA one-page analyst read on North — recommendation, valuation, rhythm, risks.→North: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Wearable computing hardware: biosignal gesture recognition
Thalmic Labs is pioneering new ways of interacting with digital devices. With a mission to merge people and technology, the company is revolutionizing how we will interact with technology in the future. Its first product, the Myo™ armband, measures electrical activity in muscles to wirelessly control computers, phones and other digital technologies, resulting in seamless interaction between humans and devices. Founded in 2012 by three graduates of the University of Waterloo's mechatronics engineering program (Stephen Lake, Matthew Bailey, Aaron Grant), Thalmic Labs has grown to a world-leading team of engineers, researchers, and creators committed to building the future of wearable technology. Thalmic Labs has raised over $140M USD to date from investors including Spark Capital, Intel Capital, Y Combinator, and others.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 8525 companies in this sector. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 96% of sector peers (real $). Modeled value above 96% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
North is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Kineolabs, Inc. | Other Technology | Seed | $2.5M | 74% |
| Wearable Devices Ltd. | Other Technology | Series A | $17.7M | 74% |
| Biostable Science & Engineering Inc | Other Technology | Series A | $115.6M | 73% |
| BioLoomics, Inc. | Other Technology | Series A | $1.6M | 73% |
| Humanoid Labs, Inc. | Software / Tech | Seed | $75.3M | 72% |
| Apton Biosystems, Inc. | Other Technology | Series B | $568.8M | 72% |
| BioFluidica, Inc. | Other Technology | Series A | $56.1M | 71% |
| Anthro Interactive Inc | Other Technology | Pre-Seed | $29.7M | 71% |
See where North sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at North, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.